Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 monthly copay.
For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline have some experts expressing concern.
A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out if you qualify.
The proportion of adults in the US taking GLP-1 medications for weight loss has reached a record high of about 40 million people.
GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications ...
Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.
Millions of people could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a ...
GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and ...
Women battling breast cancer can benefit from a phone-based weight loss program, according to a new study. The Breast Cancer Weight Loss (BWEL) program helped women drop excess pounds, improve their ...
By Chris Prentice and Amina Niasse NEW YORK, July 1 (Reuters) - Millions more Americans will qualify for obesity medications ...
Weight loss coach Lucia Murieda has launched a six-week guided one-on-one program for women over 35 who feel stuck after years of diets, fitness plans, and meal programs. A certified Neuro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results